AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Incyte to Present at Upcoming Investor Conference

May 23, 2019

WILMINGTON, Del.--(BUSINESS WIRE)--May 23, 2019--

Incyte Corporation (Nasdaq:INCY) announced today that it will present at the 40 th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019 at 2:00 pm (PDT) / 5:00 pm (EDT) in Rancho Palos Verdes.

The presentation will be webcast live and can be accessed at www.incyte.com in the Investors section under “Events and Presentations”. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s web site at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005008/en/

CONTACT: Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.comInvestors

Michael Booth, DPhil

+1 302 498 5914

mbooth@incyte.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA DELAWARE

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Incyte Corporation

Copyright Business Wire 2019.

PUB: 05/23/2019 08:00 AM/DISC: 05/23/2019 08:01 AM

http://www.businesswire.com/news/home/20190523005008/en

All contents © copyright 2019 The Associated Press. All rights reserved.